You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Papillary

Showing 76 - 100 of 8,345
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Uterine Cancer Trial in Bronx (Carboplatin and Paclitaxel and Pelvic Radiation Therapy, Carboplatin and Paclitaxel and Radiation

Completed
Has Results
  • Uterine Cancer
  • Carboplatin and Paclitaxel and Pelvic Radiation Therapy
  • Carboplatin and Paclitaxel and Radiation Therapy
  • Bronx, New York
    Montefiore Medical Center
Aug 7, 2020

Bladder Cancer, Bladder Tumor, Bladder Tumors Trial in Hanover, New York, Philadelphia (Synergo® RITE + MMC)

Terminated
  • Bladder Cancer
  • +10 more
  • Synergo® RITE + MMC
  • Hanover, Maryland
  • +3 more
Apr 14, 2020

Concordance of Molecular Classification Based on Fine Needle

Not yet recruiting
  • Papillary Thyroid Cancer
    • Calgary, Alberta, Canada
      Foothills Medical Centre
    Nov 17, 2023

    Kidney Cancer Trial in France (sunitinib malate)

    Completed
    • Kidney Cancer
    • sunitinib malate
    • Angers, France
    • +21 more
    Feb 18, 2021

    Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,

    Completed
    Has Results
    • Ovarian Endometrioid Adenocarcinoma
    • +8 more
    • Jacksonville, Florida
    • +1 more
    Sep 28, 2020

    Papillary Thyroid Carcinoma Trial in Zagazig (Total thyroidectomy and central neck dissection)

    Unknown status
    • Papillary Thyroid Carcinoma
    • Total thyroidectomy and central neck dissection
    • Zagazig, Egypt
      Zagazig University Hospitals
    Apr 2, 2020

    Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:

    Terminated
    • Transitional Cell Carcinoma
    • +3 more
    • CG0070 Adenovirus Vector
    • Control Arm: Quadruple Choice
    • Phoenix, Arizona
    • +6 more
    Apr 12, 2021

    Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory

    Active, not recruiting
    • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
    • +5 more
    • Crizotinib (PF-02341066)
    • Brussels, Belgium
    • +24 more
    May 9, 2022

    Papillary Thyroid Cancer Trial (Radioiodine)

    Not yet recruiting
    • Papillary Thyroid Cancer
    • (no location specified)
    May 6, 2020

    Positron-Emission Tomography, Lymph Node Metastases, Thyroid Cancer Trial in Guangzhou (<Sup>18<Sup>F-FDG PET/CT dynamic scan,

    Recruiting
    • Positron-Emission Tomography
    • +2 more
    • <Sup>18<Sup>F-FDG PET/CT dynamic scan
    • B-ultrasonography
    • Guangzhou, Guangdong, China
      Fifth Affiliated Hospital, Sun Yat-Sen University
    Jul 27, 2022

    Thyroid Tumors Trial in Lexington (Lenalidomide)

    Completed
    Has Results
    • Thyroid Neoplasms
    • Lexington, Kentucky
      University of Kentucky Markey Cancer Center
    May 28, 2020

    Postoperative Re-stratification for Recurrence in

    Completed
    • Well Differentiated Thyroid Carcinoma
    • Papillary Thyroid Cancer
    • UNILATERAL THYROIDECTOMY
    • (no location specified)
    Aug 4, 2020

    Papillary Renal Cell Carcinoma Trial in France (axitinib)

    Completed
    • Papillary Renal Cell Carcinoma
    • Angers, France
    • +9 more
    Feb 19, 2020

    Pancreas Cyst Trial in Mannheim (Next Generation Sequencing, CEA and lipase, Cytology)

    Completed
    • Pancreas Cyst
    • Next Generation Sequencing
    • +3 more
    • Mannheim, Germany
      Tertiary referral hospital: Theresienkrankenhaus und St. Hedwig
    Dec 17, 2022

    Uterine Cancer Trial in Baltimore (Letrozole, Everolimus)

    Completed
    • Uterine Cancer
    • Baltimore, Maryland
      Greater Baltimore Medical Center
    Feb 4, 2020

    Papillary Thyroid Tumors by Mass-ARRAY

    Recruiting
    • Papillary Thyroid Cancer
    • Genotyping
    • Milan, MI, Italy
      Istituto Auxologico Italiano
    Mar 10, 2023

    Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

    Recruiting
    • Papillary Thyroid Cancer
      • Milan, Italy
        Istituto Auxologico Italiano
      Mar 2, 2023

      Biomarkers of Renal Cancer

      Recruiting
      • Renal Cell Carcinoma
      • +3 more
        • Firenze, Italy
        • +3 more
        Mar 14, 2023

        Non Muscle Invasive Bladder Cancer Trial in Korea, Republic of, United States (CG0070, Pembrolizumab Injection,

        Recruiting
        • Non Muscle Invasive Bladder Cancer
        • CG0070
        • +2 more
        • Phoenix, Arizona
        • +20 more
        Jun 16, 2022

        Thyroid Papillary Carcinoma, Thyroidectomy Trial in Jinan (The Axillary Bilateral-breast Approach, The bilateral Axillo-breast

        Completed
        Has Results
        • Thyroid Papillary Carcinoma
        • Thyroidectomy
        • The Axillary Bilateral-breast Approach
        • The bilateral Axillo-breast Approach
        • Jinan, Shandong, China
          Department of thyroid and breast surgery, General Hospital of Ji
        Sep 2, 2019

        Renal Cell Carcinoma (RCC), Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in United States (CDX-014)

        Terminated
        • Renal Cell Carcinoma (RCC)
        • +5 more
        • Scottsdale, Arizona
        • +4 more
        Jun 2, 2020

        Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

        Recruiting
        • Thyroid Cancer
        • +2 more
          • Taipei, Taiwan
            Chih-Yuan Wang, M.D
          Oct 16, 2022

          Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

          Recruiting
          • Non-clear Renal Cell Carcinoma
          • Nanjing, Jiangsu, China
          • +1 more
          Mar 13, 2023